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Abstract
Background: We aimed at assessing the influence of those who are part of the parents’ social network (family, friends and health professionals) when they are making 
decisions about nutritional and respiratory support treatments for their SMA 1 children. 
Methods: We prepared a 46-question questionnaire to explore the factors that influence parents’ decisions. The influence of the different persons, the degree of 
satisfaction with the treatment elected and the consistency between the treatment information and the child’s status were assessed by the parents using a Likert scale 
of ten (a higher score for a higher influence). 
Results: The secondary-care physicians have the main influence on parent’s decisions about nutritional support (mean=6.4) and about respiratory support (mean=5.8). 
This influence is higher among decisions about Percutaneous Endoscopic Gastrostomy (mean=8.0) and among decisions about Tracheostomy Ventilation (mean=8.0). 
The degree of satisfaction with the chosen treatment is high (mean=7.9), and consistency between information about treatment and development of the illness also 
has a high score (mean=8.3). The hospital ethics committee was involved in 13.3% of the cases. 
Conclusions: The secondary-care physician influences parents’ decisions about nutritional and respiratory support, particularly while choosing PEG and TV. The 
degree of satisfaction is very high regardless of the treatment chosen. The hospital ethics committee is not usually involved in the treatment decisions for SMA1 
children.
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Introduction
Spinal muscular atrophy (SMA) is the second most common, 
potentially lethal autosomal recessive disorder [1]. This disorder 
affects 1 in 8.000 to 10.000 infants with a carrier frequency of 1 in 34 
[2]. Children with SMA type 1 can never roll, sit, or walk [3]. SMA1 is 
a progressive disease [4,5], and is usually fatal in infancy [6]. Parents 
of children with SMA1 have three options for respiratory treatment: 
letting nature take its course; tracheostomy and invasive mechanical 
ventilation (TV); continuous non- invasive respiratory muscle aid 
(NRA), including non-invasive ventilation and mechanically assisted 
cough [7]. NRA and TV can prolong survival, with NRA showing a 
lower survival probability at ages 24 and 48 months [8].
There are many studies that examine physicians’ preferences 
in managing treatments, their attitudes with regard to a particular 
disease or to specific decisions such as withholding or withdrawing 
life support treatments (LST) [9-11]. However, there are not so many 
studies examining the people that influence parents’ decisions about 
the choice of a specific treatment for their children [12]. These studies 
show that parents take decisions in a social context that change over 
time and that is influenced by relationships with family, friends and 
health professionals [13]. Also, these studies valued information that 
parents receive as a fundamental part of a decision-making process, 
and they try to measure the degree of parental satisfaction with that 
decision. We wanted to assess the influence of those who are part of the 
parents’ social network (family, friends and health professionals) when 
they are making decisions about nutritional and respiratory support 
treatments. We also wanted to assess the parents’ degree of satisfaction 
with the decisions taken and the correspondence between information 
received from the physicians and the medical condition of the child.
Methods
Subjects of our study
Data from the subjects of our research were extracted from the 
databases of the Bambino Gesù Children’s Hospital (Rome), SAPRE 
- UONPIA - Fondazione IRCCS Ca’ Granda, Ospedale Maggiore 
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Policlinico (Milan), and the families’ associations (the Associazione 
Federica, Associazione FamiglieSMA and Associazione per lo Studio 
delle Atrofie Muscolare Spinali Infantile-ASAMSI). All participants 
had to fulfill two inclusion criteria: a) to be parents of at least one 
child diagnosed with SMA1 and; b) SMA1 child’s diagnosis had 
been genetically confirmed. Three hundred and one patients fulfilled 
inclusion criteria and questionnaires were posted to their parents. The 
postal service returned 13 of them that were undelivered because the 
address was wrong or people had moved to another town. The data 
from a family was discarded because the child had a spinal muscular 
atrophy with respiratory distress and thus did not fulfill the selection 
criteria of our research, and our target population was made up of 287 
patients. At the end of June 2013, 124 participants had responded. 
Three questionnaires had more than half of the questions unanswered 
and therefore were considered invalid. The population number has 
been reduced to 121 valid responses. (response rate=42.16%).
The questionnaires
The research was conducted providing questionnaires to parents 
by postal delivery. One single questionnaire with 46 scaled questions 
about motivations for treatment choice was sent to all the parents 
(see Appendix 1). The questions were identical for both parents with 
children SMA1 alive and those parents of deceased SMA1 children. 
The questions were divided into seven sections: general information 
about the child, about the brothers and sisters, disease information, 
information about Mum, about Dad, sociological data and questions 
related to the parents’ decision process regarding the treatment. This 
last section included questions about the people that influence parents’ 
decision on nutritional and respiratory support. The questions about 
the influence of the different persons over the decision process of 
treatment, the degree of satisfaction with the treatment elected, and the 
correspondence between treatment information and the child’s status, 
were answered by parents assessing a score in a scale of ten (a higher 
score for a higher influence).
The content of the postal envelope that parents received at home was:
-A letter presenting our study.
-The questionnaire with 46 scaled questions.
-A pre-posted envelope to return the questionnaire, addressed 
to the Respiratory Medicine Service of the Bambino Gesù Children’s 
Hospital, was included.
The questionnaires were posted during March and June of 2012 
and collected until June 2013. No incentive was offered for completion 
of the questionnaire.
Statistical analysis: Results are reported as means. Inferences are 
calculated by two groups of comparison tests (2-side cues); when the 
groups were >2 ANOVA was applied, with a post-hoc Bonferroni test. 
Statistical software SPSS was used; a p<0.05 was considered statistically 
significant.
Ethical Issues: Our survey had been evaluated and approved by the 
Ethics Committee of the Bambino Gesù Children’s Hospital (Rome-
Italy) on September 15th, 2011.
Results
Coping the families of SMA1 children
There was a 51.2% of the questionnaires were only answered by 
the mother (51,2%); while 9,1% of them have only been fulfilled by the 
father. With the rest of the cases the questionnaires were completed 
jointly by the father and the mother (38.8%) and only 0.8% of cases 
were filled in by another person.
The child with SMA 1: Sex distribution shows that 52.9% of 
patients were males and 47.1% females. 62.8% of patients were born 
spontaneously while in 37.2% of cases it was necessary to perform a 
caesarean section.
Diagnosis occurred in most cases within 6 months (80.2%), between 
6 and 12 months in 18.2% of cases and 1.7% of cases after the first year 
of life. In 66.1% of cases the child had died at the time of completion of 
the questionnaire. In 76.3% of deceased patients cases death occurred 
before the age of one; 11.3% had died between the age of one and two. 
The remaining 12.5% deaths had occurred after two and half years.
Regardless of respiratory support, the number of hospitalizations 
is very low and in most cases (84.3%) less than 5 times, and only 5% 
of cases more than 11 times during the lifetime of the child. This low 
number of hospitalizations is due to improved disease management at 
home by the families and primary care health workers.
The parents: The mother is an Italian woman, whose average age at 
the time of SMA 1 child birth was 31.2 years old. In most cases (43.0%) 
she has a high school degree; she is working at the time of the survey 
(52.1%), although at the time of diagnosis of the child’s illness she had 
to change her work situation (66.0%). This change meant to leave her 
work in order to care for the sick child (39.7%) or to reduce her working 
hours (25.0%). Who normally cares for the child? In 95% of cases the 
mother is present for the responses, with 58.3% of cases displayed as 
the only career of the child. 
The father is Italian (94.2%) and he was about 34.4 years old at the 
time of the birth of the sick child. Less than a half of fathers have high 
school studies (43.8%). Currently, he is working (91.7%), and at the 
time of the child’s illness, in most of cases but less than their wives, 
changed their employment status (58.8%); the change was a reduction 
in working hours (51.4% of those who changed their status). Although 
the father participates in child care either with the mother (31.7%) or 
with the mother and another person (5.0%), the fact is that in only 2.5% 
of cases the father appears exclusively as the person who normally cares 
for the sick child. 
Before the disease 100% parents live together while after coping 
face with the illness this situation is reduced to 94.2%. Of those who 
do not live together (5.8%), 4.1% are divorced, 0.8% singles and 0.8% 
separated. These results are important if we consider that in the general 
Italian population there was a 1.81% divorce rate and 3.0% separation 
rate [14]. This means that couples with a SMA1 child have a rate of 
divorce two times higher than the general population.
The brothers and sisters: Most families had two or more children, 
including the child with SMA1 (88.1%). From them, 66.7% of parents 
responded that the brothers and sisters were acquainted about the 
disease. The main effects detected were anxiety and worry. A higher 




Exactly a half of the patients had been fed only by a nasogastric 
tube during the development of the disease; 31.7% had used also 
percutaneous endoscopic gastrostomy (PEG), while only 18.3% were 
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fed exclusively by the oral route. From the data collected, 17.3% of 
parents used TV; 40.8% used NRA and 41.8% chose NT.
People that influence treatment decisions
The secondary-care physician, i.e. pulmonologist or neurologist, 
(mean score=6.4 points out of 10) has the most influence on the 
parents’ decision about nutritional support (Figure 2). This is most 
clearly in the decision to place the PEG where the degree of influence 
of the secondary-care physician increases to values of 8.0 points. The 
pediatrician (2.8 points) and section reserved for other people (2.3 
points) are those who, after secondary-care physicians, have more 
influence on the parents’ decision.
The PEG was influenced, as expected, by the secondary-care 
physicians as compared with the oral route (mean 8.0 versus 5.0, 
p=0.02) and by relatives without medical knowledge when it was 
compared with nasogastric tube (with marginal significance only, 2.3 
versus 0.93, p=0.05). No difference was found in the other groups of 
potentially advisors.
With regard to who has more influence during the parents’ decision 
process about ventilation, the secondary-care physician also appears as 
the most influential with a mean score = 5.8 points.
The influence of the secondary-care physician is greater when 
choosing TV, which increases to 8.1 points, while less influence when 
they decide to not provide ventilatory support with only 3.2 points out 
of 10. The pediatrician and other people have less influence during the 
decision process of respiratory support (Figure 3).
The degree of satisfaction and the adequacy on treatment 
information
The degree of satisfaction with the decision on the form of nutrition 
is high (mean score = 7.9 points out of 10) and consistency between 
the information received and present conditions of the child (mean 
score = 8.3 points out of 10) is also high. These results are significant 
when comparing the degree of satisfaction with the form of nutritional 
support: oral nutrition, nasogastric tube and PEG (Figure 4a), with 
no significant difference between the three forms. The same is true 
when studying the adequacy on treatment information regarding the 
nutritional support (Figure 4b).
This data remains when we analyze the degree of parental 
satisfaction about the ventilatory support decision, which is high 
(mean=7.9 and median=10). There is a significant difference (p=0.003) 
in interquartile range (3 for TV; 2 for NRA; 1,25 for NT) (Figure 4c). 
Also the scores about the correspondence between information given 
by physicians regarding ventilation and the children status are high 
(mean=7.8 and median=10). There is a significant result when studying 
the adequacy on treatment information for the type of respiratory 
support: TV, NRA and NT (Figure 4d), with a significant difference 
(p=0.006) that shows a minor interquartile rank for NT=1 and a higher 
interquartile rank for NRA and for TV (3 for NRA and 4 for TV).
When we carefully studied the low score extreme cases, we saw 
that some cases correspond with situations in which the parents had 
1=more anxious and worried; 2=most in need of affection; 3=more angry and undisciplined; 
4=more cuddly; 5=more responsible for; 6=other
Figure 1. Main effects of the disease in siblings.
 
The graph shows the value that parents give to the influence of others during the decision 
process about the kind of nutrition: First column=oral nutrition; second column=nasogastric 
tube and third column=PEG. People that can influence: 1=Familiar without any medical 
knowledge; 2=familiar with medical knowledge; 3= Pediatrician; 4=Secondary-care 
physician; 5=Friends without any medical knowledge; 6=Friends with medical knowledge; 
7=Spiritual  guide; and 8=Other people (usually SMA associations or institutions that attend 
children and parents’ necessities)
Figure 2. Question D.40, Rating of different people’s influence during parents` decision 
process about type of nutrition.
 
The graph shows the value that parents give to the influence of others during the decision 
process about the type of ventilatory support: First column=invasive ventilation; Second 
column=noninvasive ventilation and third column=to not provide ventilatory support. 
People that can influence: 1=Familiar without any medical knowledge; 2=familiar with 
medical knowledge; 3=Pediatrician; 4=Secondary-care physician; 5=Friends without any 
medical knowledge; 6=Friends with medical knowledge; 7=Spiritual guide; and 8=Other 
people (usually SMA families associations or institutions that attend children and parents’ 
necessities).
Figure 3. Question D.43. Rating different people’s influence during parents` decision 
process about type of ventilator support.
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not participated in the decision process about the nutritional and 
respiratory support treatment for their child (Figure 4).
Participation of the Hospital Ethics Committee
On a sample size of n=105, parents said that the hospital ethics 
committee was not involved in the decision making process (47.6%) 
and only 13.3% of responses said that the committee participated in it. 
A considerable proportion (39%) did not know if the committee had 
been involved in the decision making process. These responses show 
that hospital ethics committees are not usually involved in decisions 
about LST for SMA1 children.
Discussion
Who influences the treatment decision process?
We observed that the means of the influence of the various 
potential advisors are very low and almost insignificant, except for the 
secondary-care physician. Some data may be subject to closer scrutiny; 
i.e. the little influence of the family on parents when they decided to not 
give ventilatory support. The parents know that the decision to deny 
ventilatory support is an option that limits the life expectancy of the 
child and that this decision is made relying on the medical expertise of 
the specialists and the experience of other parents with SMA1 children.
Ventilation (TV or NRA) was influenced more than NT when 
the secondary-care physicians were examined (NT mean= 3.2 versus, 
respectively TV mean =8.1 and NRA mean = 7.1, p<0.001), while 
relatives or friends without medical knowledge influenced NRA versus 
NT (relatives NRA mean =2.4 versus NT mean =0.4, and friends NRA 
mean =1.3 versus NT mean =0.0, in both cases p=0.01)
These results are important if we consider the last international 
survey on physician / tracheostomy SMA1 ratio revealed that only 60% 
of respondents considered medical TV as an acceptable treatment for 
SMA1 children who had chronic respiratory failure [17], while in the 
same survey, most physicians (86%) favor long-term NRA in SMA1 
children.
Only 51% of physicians surveyed by Benson knew the new treatment 
protocols approved for the SMA1 children [17]. If medical experts 
do not know the protocols then, on what basis do they recommend 
treatment? Recommendations are based on their experience with SMA1 
children with TV. Physicians with SMA1 TV patients are more likely 
to recommend TV to future patients, while those without experience 
with SMA1 TV patients are less inclined to recommend TV [16-17,20]. 
This is important to the education of secondary- care physicians in the 
treatment protocols approved by the various international committees 
for children with SMA1 [33].
 
Some extreme low score cases correspond with situations in which the parents do not participate in the decision process of treatment: Case 47 corresponds to a child who was intubated 
during a respiratory crisis, without the parents’ consent. In case 50 the parents could not choose the treatment and was the secondary-care physicians who decided NT for their child. Case 
64 corresponds to a child whose parents had to face doctors in order to choose TV for their child.
Figure 4. Parents’ satisfaction with nutritional and ventilator support, and adequacy between information about the treatments and the child’s status. a) Parents’ satisfaction regarding 
nutritional support decision. b) Correspondence between information about nutritional support and the condition of the child. c) Parents’ satisfaction regarding ventilatory support 
decision. d) Correspondence between information about ventilatory support and the child status.
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The degree of satisfaction with decisions about treatments
We have seen that parental satisfaction is very high regarding 
their decisions of treatments for respiratory and nutritional support. 
This data is consistent with that obtained in other studies [12]. Some 
extreme low score cases corresponded with situations in which the 
parents had not participated in the decisions process about treatment 
(Figure 4). The exclusion of families in the decision process is contrary 
to disease management protocols [21,22]. Dissatisfaction is generated 
when the family preferences are not taken into account.
What is the correspondence between the information 
provided by physicians and the medical condition of the 
child?
As for the correspondence between the information received and 
the child’s development the results are also very high. Other studies 
show high parental satisfaction with the information received [13]. 
The information received is one of the factors that parents considered 
fundamental when deciding, valuing information that is clear and 
appropriate to the evolution of the child’s illness [12,15]. Protocols 
emphasize the necessity to give all treatment options to parents with full 
and clear information [21-23], and this is what parents demand [15]. 
Doctors must avoid the paternalistic attitudes in hiding information 
about possible treatments, for example, long-term TV [24]. It is clear 
that parents cannot make decisions about accepting a treatment or not 
for their SMA1child unless the doctor told them the truth about child’s 
condition and its evolution [24]. Access to information on the Internet 
makes parents to question the doctors’ approach when they do not 
offer all the possible options of treatment.
Statistical weakness
On the one hand, our study achieved a respectable size (n=121) 
compared to other studies about parents of children with SMA1 [18-
19]. But, on the other hand, the weakness of our sample prevented us 
from doing a factor analysis to firmly establish associations with other 
factors such as geographic location or parents’ religious status. Our 
results are limited to a country (Italy) with a specific cultural context. 
For this reason, our data should serve as a starting point to larger 
and statistically more significant studies to corroborate or refute the 
analysis carried out. 
Retrospective nature of our motivational study
Our research is a retrospective study. This means that we 
questioned parents about a decision that they made in the past. Such 
methodology implies a pre-conceived idea about what kind of people 
could influence the parents during the decision-making process. In 
addition, this methodology requires from parents the effort to collect 
and also of organize their thoughts and feelings, and bring them from 
the past into the present.
Conclusions
The secondary-care physician (pulmonologist or neurologist) has 
the most influence on the parents’ decisions concerning nutritional and 
respiratory support. This also on influence is even clearly manifested 
when choosing PEG and when choosing TV. The degree of satisfaction 
of the decision is very high in both (nutritional and respiratory 
support), regardless of the option chosen for respiratory and nutritional 
status. Extremely low cases, in terms of satisfaction, are related not to 
the type of ventilation or nutrition, but with no family involvement 
during the treatment decision process, regardless of the decision taken. 
The correspondence between the treatment information provided by 
the medical team and the evolution of the disease is very high. The 
ethics committees of the hospital are not usually involved in treatment 
decision process for SMA1 children.
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